For example, LINC01554-mediated glucose metabolism reprogramming could suppress the tumorigenicity of HCC through the downregulation of PKM2 expression and inhibition of the Akt/mTOR signaling pathway [44]. This evidence concerns the gene MTOR and hepatocellular carcinoma.